NXTC – Nextcure Inc
NXTC
$0.3612Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,116,020.00
EPSttm : -1.99
NextCure, Inc.
$0.3612
Float Short %
0.27
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.02
EPS Last/This Y
0.24
EPS This/Next Y
0.17
Price
0.36
Target Price
3
Analyst Recom
1
Performance Q
-52.85
Relative Volume
1.97
Beta
1.15
Ticker: NXTC
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-03-20 | NXTC | 0.61 | 0.00 | 0.00 | 138 |
2025-03-21 | NXTC | 0.5746 | 0.00 | 0.00 | 138 |
2025-03-24 | NXTC | 0.59 | 0.00 | 0.00 | 40 |
2025-03-25 | NXTC | 0.5544 | 0.00 | 0.00 | 40 |
2025-03-26 | NXTC | 0.5291 | 0.00 | 0.00 | 40 |
2025-03-27 | NXTC | 0.511 | 0.00 | 0.00 | 40 |
2025-03-28 | NXTC | 0.5091 | 0.00 | 0.00 | 40 |
2025-03-31 | NXTC | 0.484 | 0.00 | 0.00 | 40 |
2025-04-01 | NXTC | 0.4406 | N/A | N/A | 0 |
2025-04-02 | NXTC | 0.3996 | 0.00 | 0.00 | 45 |
2025-04-03 | NXTC | 0.397 | 0.00 | 0.00 | 45 |
2025-04-04 | NXTC | 0.39 | 0.00 | 0.00 | 45 |
2025-04-07 | NXTC | 0.4019 | 0.00 | 0.00 | 45 |
2025-04-08 | NXTC | 0.32 | 0.00 | 0.00 | 45 |
2025-04-09 | NXTC | 0.2827 | 0.00 | 0.00 | 45 |
2025-04-10 | NXTC | 0.27 | 0.00 | 0.00 | 45 |
2025-04-11 | NXTC | 0.2902 | 0.00 | 0.00 | 45 |
2025-04-14 | NXTC | 0.32 | 0.00 | 0.00 | 46 |
2025-04-15 | NXTC | 0.3301 | 0.00 | 0.00 | 47 |
2025-04-16 | NXTC | 0.3224 | 0.00 | 0.00 | 47 |
2025-04-17 | NXTC | 0.3519 | 0.00 | 0.00 | 47 |
2025-04-18 | NXTC | 0.3612 | 0.00 | 0.00 | 47 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-03-20 | NXTC | 0.61 | 23.4 | - | -1.75 |
2025-03-21 | NXTC | 0.58 | 23.4 | - | -1.75 |
2025-03-24 | NXTC | 0.61 | 23.4 | - | -1.75 |
2025-03-25 | NXTC | 0.57 | 23.4 | - | -1.75 |
2025-03-26 | NXTC | 0.53 | 23.4 | - | -1.75 |
2025-03-27 | NXTC | 0.52 | 23.4 | - | -1.75 |
2025-03-28 | NXTC | 0.50 | 23.4 | - | -1.75 |
2025-03-31 | NXTC | 0.48 | 23.4 | - | -1.75 |
2025-04-01 | NXTC | 0.44 | 23.4 | - | -1.75 |
2025-04-02 | NXTC | 0.40 | 23.4 | - | -1.75 |
2025-04-03 | NXTC | 0.40 | 23.4 | - | -1.75 |
2025-04-04 | NXTC | 0.39 | 23.4 | - | -1.75 |
2025-04-07 | NXTC | 0.38 | 23.4 | - | -1.75 |
2025-04-08 | NXTC | 0.33 | 23.4 | - | -1.75 |
2025-04-09 | NXTC | 0.29 | 23.4 | - | -1.75 |
2025-04-10 | NXTC | 0.27 | 23.4 | - | -1.75 |
2025-04-11 | NXTC | 0.29 | 23.4 | - | -1.75 |
2025-04-14 | NXTC | 0.31 | 23.4 | - | -1.75 |
2025-04-15 | NXTC | 0.33 | 23.4 | - | -1.75 |
2025-04-16 | NXTC | 0.34 | 23.4 | - | -1.75 |
2025-04-17 | NXTC | 0.36 | 23.4 | - | -1.75 |
2025-04-18 | NXTC | 0.36 | 23.4 | - | -1.75 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-03-20 | NXTC | 0.00 | -15.71 | 0.31 |
2025-03-21 | NXTC | 0.00 | -15.71 | 0.31 |
2025-03-24 | NXTC | 0.00 | -15.71 | 0.31 |
2025-03-25 | NXTC | 0.00 | -15.71 | 0.31 |
2025-03-26 | NXTC | 0.00 | -15.71 | 0.30 |
2025-03-27 | NXTC | 0.00 | -15.71 | 0.30 |
2025-03-28 | NXTC | 0.00 | -15.71 | 0.30 |
2025-03-31 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-01 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-02 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-03 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-04 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-07 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-08 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-09 | NXTC | 0.00 | -15.24 | 0.30 |
2025-04-10 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-11 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-14 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-15 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-16 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-17 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-18 | NXTC | 0.00 | -15.24 | 0.27 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.41
Avg. EPS Est. Current Quarter
-0.4
Avg. EPS Est. Next Quarter
-0.42
Insider Transactions
Institutional Transactions
-15.24
Beta
1.15
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
21
Sentiment Score
79
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.3
Target Price
3
P/E
Forward P/E
PEG
P/S
P/B
0.15
P/Free Cash Flow
EPS
-1.99
Average EPS Est. Cur. Y
-1.75
EPS Next Y. (Est.)
-1.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.97
Return on Equity vs Sector %
-105
Return on Equity vs Industry %
-91.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.23
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading